Artemis Investment Management LLP Amgen Inc Transaction History

Artemis Investment Management LLP

$7.52 Billion
Q1 2024

A detailed history of Artemis Investment Management LLP transactions in Amgen Inc stock. As of the latest transaction made, Artemis Investment Management LLP holds 15,957 shares of AMGN stock, worth $4.96 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

15,957

Previous 30,449 47.59%

Holding current value

$4.96 Million

Previous $8.77 Million 48.27%

% of portfolio

0.06%

Previous 0.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $3.9 Million - $4.7 Million	-14,492 Reduced 47.59%	15,957 $4.54 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $350,564 - $395,478	-1,371 Reduced 4.31%	30,449 $8.77 Million
Q3 2023 Oct 16, 2023	BUY	$218.65 - $271.46 $6.96 Million - $8.64 Million	31,820 New	31,820 $8.55 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $9.08 Million - $10.4 Million	-45,653 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $1.2 Million - $1.41 Million	-5,662 Reduced 11.03%	45,653 $9.7 Million

Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $1.59 Million - $1.77 Million	6,825 Added 15.34%	51,315 $12.5 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $102,078 - $118,956	460 Added 1.04%	44,490 $11.1 Million
Q4 2020 Jan 26, 2021	BUY	$216.38 - $257.67 $1.89 Million - $2.25 Million	8,718 Added 24.69%	44,030 $10.1 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $9.28 Million - $10.3 Million	-39,555 Reduced 52.83%	35,312 $8.97 Million
Q2 2020 Jul 27, 2020	SELL	$197.81 - $242.74 $4.71 Million - $5.78 Million	-23,795 Reduced 24.12%	74,867 $17.7 Million
Q1 2020 Apr 14, 2020	SELL	$182.24 - $241.7 $10.1 Million - $13.4 Million	-55,325 Reduced 35.93%	98,662 $20 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $870,744 - $1.12 Million	-4,602 Reduced 2.9%	153,987 $37.1 Million
Q3 2019 Oct 10, 2019	SELL	$174.11 - $208.62 $2.61 Million - $3.13 Million	-15,009 Reduced 8.65%	158,589 $30.7 Million
Q2 2019 Jul 24, 2019	SELL	$166.7 - $195.41 $750,316 - $879,540	-4,501 Reduced 2.53%	173,598 $32 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $5.17 Million - $5.82 Million	-28,562 Reduced 13.82%	178,099 $33.8 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $15.9 Million - $18.5 Million	88,968 Added 75.59%	206,661 $40.3 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $13.3 Million - $15 Million	71,806 Added 156.48%	117,693 $24.4 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $1.48 Million - $1.67 Million	-8,933 Reduced 16.3%	45,887 $8.47 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $590,463 - $690,030	-3,485 Reduced 5.98%	54,820 $9.35 Million
Q4 2017 Feb 08, 2018	SELL	$168.79 - $188.59 $13.5 Million - $15.1 Million	-79,944 Reduced 57.83%	58,305 $10.1 Million
Q3 2017 Oct 31, 2017	SELL	$167.29 - $191.0 $272,348 - $310,948	-1,628 Reduced 1.16%	138,249 $25.8 Million
Q2 2017 Aug 09, 2017	BUY	N/A	139,877	139,877 $24.1 Million

Others Institutions Holding AMGN

# of Institutions

2,932

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.

Account

Artemis Investment Management LLP Amgen Inc Transaction History